Global data hub supporting HIV and related infection treatments
Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)
This project runs the data and statistics hub that helps test new treatments for adults living with HIV and related infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University D/b/a Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11231235 on NIH RePORTER |
What this research studies
If I join an ACTG effort, this center organizes and manages the data from the studies I might join. It brings together statisticians, epidemiologists, and data managers to keep patient and lab data accurate, secure, and ready for analysis. The team supports studies on durable HIV treatments, strategies to control HIV without daily ART, better TB care in people with HIV, and cures for hepatitis B co-infection. They also make sure study data follow regulatory rules and help run trials at clinics around the world that enroll adults with HIV.
Who could benefit from this research
Good fit: Ideal candidates for the trials this center supports are adults living with HIV, including those with TB co-infection or chronic hepatitis B.
Not a fit: People without HIV and children/young people under the adult age cutoff for these trials are unlikely to benefit from this specific program.
Why it matters
Potential benefit: If successful, this center could speed up trustworthy results that lead to better treatments and care for adults with HIV and related infections.
How similar studies have performed: ACTG and other clinical networks have a long track record of producing effective HIV treatments and improved care, so this work builds on proven clinical trial systems.
Where this research is happening
Boston, United States
- Harvard University D/b/a Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Hughes, Michael David — Harvard University D/b/a Harvard School of Public Health
- Study coordinator: Hughes, Michael David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.